933702-55-7Relevant articles and documents
Self-Replication and Amplification of Enantiomeric Excess of Chiral Multifunctionalized Large Molecules by Asymmetric Autocatalysis
Kawasaki, Tsuneomi,Nakaoda, Mai,Takahashi, Yutaro,Kanto, Yusuke,Kuruhara, Nanako,Hosoi, Kenji,Sato, Itaru,Matsumoto, Arimasa,Soai, Kenso
, p. 11199 - 11202 (2014)
Self-replication of large chiral molecular architectures is one of the great challenges and interests in synthetic, systems, and prebiotic chemistry. Described herein is a new chemical system in which large chiral multifunctionalized molecules possess asymmetric autocatalytic self-replicating and self-improving abilities, that is, improvement of their enantioenrichment in addition to the diastereomeric ratio. The large chiral multifunctionalized molecules catalyze the production of themselves with the same structure, including the chirality of newly formed asymmetric carbon atoms, in the reaction of the corresponding achiral aldehydes and reagent. The chirality of the large multifunctionalized molecules controlled the enantioselectivity of the reaction in a highly selective manner to construct multiple asymmetric stereogenic centers in a single reaction.
2 -Chloro -5-aldehyde pyrimidine and preparation method thereof
-
Paragraph 0052-0071, (2019/07/04)
The invention discloses 2-chloro-5-aldehyde pyrimidine and a preparation method thereof. The preparation method comprises the following steps: step 1, adding Arnold salt into a solvent to obtain an arnold salt solution, the chemical structural formula of the Arnold salt is as shown in the specification (I); and step 2, adding chloroformamidine hydrochloride and an alkali into the Arnold salt solution to carry out ring-closing reaction so as to obtain the 2-chloro-5-aldehyde pyrimidine.
NUCLEIC ACID-BINDING PHOTOPROBES AND USES THEREOF
-
Paragraph 0050, (2019/06/17)
The present invention relates to photoactivatable compounds and methods of use thereof for determining binding site and other structural information about RNA transcripts. The invention also provides methods of identifying RNA transcripts that bind compounds and are thus druggable, methods of screening drug candidates, and methods of determining drug binding sites and/or accessible or reactive sites on a target RNA.